-
IntroducedJun 07, 2023
-
Passed House
-
Passed Senate
-
Became Law
United States House Bill
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
Last Action See all actions
Senate • Sep 24, 2024: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Latest Bill Text See all bill texts
Summary
Comments on HR 3884
Tweets
Whip Lists
Sponsors



- Rep. Lee, Barbaracosponsor
Votes
Actions
- Sep 24, 2024 | Senate
- Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Sep 23, 2024 | House
- Mr. Bucshon moved to suspend the rules and pass the bill, as amended.
- Considered under suspension of the rules. (consideration: CR H5578-5580)
- DEBATE - The House proceeded with forty minutes of debate on H.R. 3884.
- Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5578)
- On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5578)
- Motion to reconsider laid on the table Agreed to without objection.
- Aug 25, 2023 | House
- Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-166.
- Placed on the Union Calendar, Calendar No. 132.
- Jul 19, 2023 | House
- Committee Consideration and Mark-up Session Held.
- Ordered to be Reported (Amended) by the Yeas and Nays: 50 - 0.
- Jul 13, 2023 | House
- Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 28 - 0.
- Subcommittee Consideration and Mark-up Session Held
- Jun 09, 2023 | House
- Referred to the Subcommittee on Health.
- Jun 07, 2023 | House
- Introduced in House
- Referred to the House Committee on Energy and Commerce.
